UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 8, 2016

 

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

MICHIGAN		0-17988		38-2367843
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

620 Lesher Place Lansing, Michigan		48912
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code 517-372-9200

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 8, 2016, A. Charles Fischer informed the Board of Directors of the Company that he would be resigning from the Board, effective that date, due to health reasons.

Mr. Fischer, 76, has been a member of the Board of Directors since 2006; his term expires at the Company’s annual meeting in 2018. The Company advises that the Board of Directors expects to appoint an interim director to complete Mr. Fischer’s term.

A copy of the press release issued by the Registrant to announce the above is attached to this Current Report as Exhibit 99. This press release is being furnished to, as opposed to filed with, the Securities and Exchange Commission

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.     Press Release issued by the Registrant on December 14, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

						NEOGEN CORPORATION
						(Registrant)
Date: December 14, 2016
						/s/ Steven J. Quinlan
						Steven J. Quinlan
						Vice President & CFO